111(YI) Prnewswire·2025-02-20 10:00Core Viewpoint - 111, Inc. is set to report its unaudited financial results for the fourth quarter and fiscal year 2024 on March 20, 2025, indicating a focus on transparency and communication with investors [1]. Company Overview - 111, Inc. is a leading tech-enabled healthcare platform in China, aiming to reshape the healthcare value chain by digitally empowering both upstream and downstream sectors [4]. - The company provides consumers with improved access to pharmaceutical products and healthcare services through its online retail pharmacy, 1 Pharmacy, and its offline virtual pharmacy network [4]. - 111, Inc. also offers online healthcare services via its internet hospital, 1 Clinic, which includes online consultations, electronic prescriptions, and patient management services [4]. - The company operates 1 Medicine, an online platform that serves as a one-stop shop for pharmacies to source a wide range of pharmaceutical products [4]. - With the largest virtual pharmacy network in China, 111, Inc. enhances the ability of offline pharmacies to serve customers through cloud-based services [4]. - The company provides an omni-channel drug commercialization platform to strategic partners, offering services such as digital marketing, patient education, data analytics, and pricing monitoring [4]. Earnings Conference Call - The management team will host an earnings conference call on March 20, 2025, at 7:30 AM U.S. Eastern Time, allowing stakeholders to engage directly with the company's financial performance [2]. - Participants must register in advance to receive dial-in information, ensuring organized communication during the call [2][3]. - A live and archived webcast of the conference call will be available on the company's website, providing additional access to the information shared [3].